Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) EBT Margin (2016 - 2025)

Bio Key International's EBT Margin history spans 16 years, with the latest figure at 62.26% for Q3 2025.

  • For Q3 2025, EBT Margin fell 2781.0% year-over-year to 62.26%; the TTM value through Sep 2025 reached 67.71%, up 862.0%, while the annual FY2024 figure was 62.39%, 4922.0% up from the prior year.
  • EBT Margin for Q3 2025 was 62.26% at Bio Key International, up from 68.8% in the prior quarter.
  • Across five years, EBT Margin topped out at 4.87% in Q2 2021 and bottomed at 284.52% in Q4 2022.
  • The 5-year median for EBT Margin is 77.31% (2023), against an average of 98.38%.
  • The largest annual shift saw EBT Margin skyrocketed 64419bps in 2021 before it plummeted -9980bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 215.74% in 2021, then plummeted by -32bps to 284.52% in 2022, then surged by 49bps to 145.18% in 2023, then skyrocketed by 34bps to 96.25% in 2024, then skyrocketed by 35bps to 62.26% in 2025.
  • Per Business Quant, the three most recent readings for BKYI's EBT Margin are 62.26% (Q3 2025), 68.8% (Q2 2025), and 45.83% (Q1 2025).